Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysis

Hematology

Volumn 21, Issue 4, 2016, Pages 234-240

  Sriram, Swetha ^a   Xenocostas, Anargyros ^a   Lazo Langner, Alejandro ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Aged; Anemia; Elderly; Erythropoietin; Geriatric

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; EPO PROTEIN, HUMAN;

AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CYANOCOBALAMIN DEFICIENCY; ERYTHROID CELL; FEMALE; FOLIC ACID DEFICIENCY; GENETIC HETEROGENEITY; HEMODIALYSIS; HUMAN; IRON DEFICIENCY ANEMIA; MALE; META ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VERY ELDERLY; BLOOD; COMPARATIVE STUDY; PATHOLOGY;

ANEMIA; ERYTHROPOIETIN; FEMALE; HUMANS; MALE;

EID: 84983455694     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245332.2015.1101972     Document Type: Article

References (30)

1. S.D.Denny, M.N.Kuchibhatla, H.J.Cohen. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med. 2006;119(4):327–34. doi:10.1016/j.amjmed.2005.08.027
2. B.W.Penninx, J.M.Guralnik, G.Onder, L.Ferrucci, R.B.Wallace, M.Pahor Anemia and decline in physical performance among older persons. Am J Med. 2003;115(2):104–10. doi:10.1016/S0002-9343(03)00263-8
3. B.W.Penninx, S.M.Pluijm, P.Lips, R.Woodman, K.Miedema, J.M.Guralnik, Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc. 2005;53(12):2106–11. doi:10.1111/j.1532-5415.2005.00491.x
4. E.A.Price, R.Mehra, T.H.Holmes, S.L.Schrier Anemia in older persons:etiology and evaluation. Blood Cells Mol Dis. 2011;46(2):159–65. doi:10.1016/j.bcmd.2010.11.004
5. A.S.Artz, D.Fergusson, P.J.Drinka, M.Gerald, R.Bidenbender, A.Lechich, Mechanisms of unexplained anemia in the nursing home. J Am Geriatr Soc. 2004;52(3):423–7. doi:10.1111/j.1532-5415.2004.52116.x
6. A.S.Artz, M.J.Thirman Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic. J Gerontol A Biol Sci Med Sci. 2011;66(8):925–32. doi:10.1093/gerona/glr090
7. J.M.Guralnik, R.S.Eisenstaedt, L.Ferrucci, H.G.Klein, R.C.Woodman Prevalence of anemia in persons 65 years and older in the United States:evidence for a high rate of unexplained anemia. Blood 2004;104(8):2263–8. doi:10.1182/blood-2004-05-1812
8. R.Eisenstaedt, B.W.Penninx, R.C.Woodman Anemia in the elderly:current understanding and emerging concepts. Blood Rev. 2006;20(4):213–26. doi:10.1016/j.blre.2005.12.002
9. I.Beerman, W.J.Maloney, I.L.Weissmann, D.J.Rossi Stem cells and the aging hematopoietic system. Curr Opin Immunol. 2010;22(4):500–6. doi:10.1016/j.coi.2010.06.007
10. S.Chateauvieux, C.Grigorakaki, F.Morceau, M.Dicato, M.Diederich Erythropoietin, erythropoiesis and beyond. Biochem Pharmacol. 2011;82(10):1291–303. doi:10.1016/j.bcp.2011.06.045
11. J.Waalen, K.von Lohneysen, P.Lee, X.Xu, J.S.Friedman Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol. 2011;87(2):107–16. doi:10.1111/j.1600-0609.2011.01631.x
12. G.Wells, B.Shea, D.O'Connell, J.Peterson, V.Welch, M.Losos, The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2011.
13. J.O.Friedrich, N.K.Adhikari, J.Beyene The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis:a simulation study. BMC Med Res Methodol. 2008;8:32. doi:10.1186/1471-2288-8-32
14. P.Macaskill, C.Gatsonis, J.Deeks, R.Harbord, Y.Takwoingi Chapter 10:Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy, Version 1 0 The Cochrane Collaboration. 2010.
15. Review manager (RevMan) [computer program]. version 5.2. Copenhagen:The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
16. K.Kario, T.Matsuo, K.Kodama, K.Nakao, R.Asada Reduced erythropoietin secretion in senile anemia. Am J Hematol. 1992;41(4):252–7. doi:10.1002/ajh.2830410406
17. W.P.den Elzen, A.J.de Craen, E.T.Wiegerinck, R.G.Westendorp, D.W.Swinkels, J.Gussekloo. Plasma hepcidin levels and anemia in old age. the Leiden 85-plus study. Haematologica 2013;98(3):448–54. doi:10.3324/haematol.2012.068825
18. L.Ferrucci, J.M.Guralnik, S.Bandinelli, R.D.Semba, F.Lauretani, A.Corsi, Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol. 2007;136(6):849–55. doi:10.1111/j.1365-2141.2007.06502.x
19. W.Jelkmann Regulation of erythropoietin production. J Physiol. 2001;589:1251–8. doi:10.1113/jphysiol.2010.195057
20. W.Denny Giving anemia a boost with inhibitors of prolyl hydroxylase. J Med Chem. 2012;55:2943–4. doi:10.1021/jm300314a
21. L.Ferrucci, R.D.Semba, J.M.Guralnik, W.B.Ershler, S.Bandinelli, K.V.Patel, Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010;115(18):3810–6. doi:10.1182/blood-2009-02-201087
22. P.Lee, T.Gelbart, J.Waalen, E.Beutler The anemia of ageing is not associated with increased plasma hepcidin levels. BCMD 2008;41:252–4.
23. A.Ble, J.C.Fink, R.C.Woodman, M.A.Klausner, B.G.Windham, J.M.Guralnik, Renal function, erythropoietin, and anemia of older persons:the InCHIANTI study. Arch Intern Med. 2005;165(19):2222–7. doi:10.1001/archinte.165.19.2222
24. W.M.Michels, D.C.Grootendorst, M.Verduijn, E.G.Elliott, F.W.Dekker, R.T.Krediet Performance of the Cockcroft–Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–9. doi:10.2215/CJN.06870909
25. C.Bauer, A.Kurtz Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol. 1989;51:845–56. doi:10.1146/annurev.ph.51.030189.004213
26. W.M.Bernhardt, M.S.Wiesener, P.Scigalla, J.Chou, R.E.Schmieder, V.Gunzler, Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol. 2010;21(12):2151–6. doi:10.1681/ASN.2010010116
27. M.M.Hsieh, N.S.Linde, A.Wynter, M.Metzger, C.Wong, I.Langsetmo, HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood 2007;110(6):2140–7. doi:10.1182/blood-2007-02-073254
28. J.M.Guralnik, W.B.Ershler, S.L.Schrier, V.J.Picozzi Anemia in the elderly:a public health crisis in hematology. Hematology Am Soc Hematol Educ Program 2005:528–32. doi:10.1182/asheducation-2005.1.528
29. J.Vinhas, C.Barreto, J.Assuncao, L.Parreira, A.Vaz Treatment of anaemia with erythropoiesis-stimulating agents in patients with chronic kidney disease does not lower mortality and may increase cardiovascular risk:a meta-analysis. Nephron 2012;121(3–4):95–101.
30. M.Wagner, A.Alam, J.Zimmermann, K.Rauh, A.Koljaja-Batzner, U.Raff, Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(7):1573–9. doi:10.2215/CJN.00380111